117 related articles for article (PubMed ID: 29099720)
1. Derivation of mean dose tolerances for new fractionation schemes and treatment modalities.
Perkó Z; Bortfeld T; Hong T; Wolfgang J; Unkelbach J
Phys Med Biol; 2018 Feb; 63(3):035038. PubMed ID: 29099720
[TBL] [Abstract][Full Text] [Related]
2. Optimization of combined proton-photon treatments.
Unkelbach J; Bangert M; De Amorim Bernstein K; Andratschke N; Guckenberger M
Radiother Oncol; 2018 Jul; 128(1):133-138. PubMed ID: 29370987
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous optimization of dose distributions and fractionation schemes in particle radiotherapy.
Unkelbach J; Zeng C; Engelsman M
Med Phys; 2013 Sep; 40(9):091702. PubMed ID: 24007135
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
6. Optimal combined proton-photon therapy schemes based on the standard BED model.
Ten Eikelder SCM; den Hertog D; Bortfeld T; Perkó Z
Phys Med Biol; 2019 Mar; 64(6):065011. PubMed ID: 30641502
[TBL] [Abstract][Full Text] [Related]
7. Accounting for Range Uncertainties in the Optimization of Combined Proton-Photon Treatments Via Stochastic Optimization.
Fabiano S; Bangert M; Guckenberger M; Unkelbach J
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):792-801. PubMed ID: 32361008
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study of spatiotemporally integrated radiotherapy using the LQ model.
Kim M; Phillips MH
Phys Med Biol; 2018 Dec; 63(24):245016. PubMed ID: 30523816
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy.
Unkelbach J; Papp D; Gaddy MR; Andratschke N; Hong T; Guckenberger M
Radiother Oncol; 2017 Nov; 125(2):357-364. PubMed ID: 28951010
[TBL] [Abstract][Full Text] [Related]
10. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
[TBL] [Abstract][Full Text] [Related]
11. The emergence of nonuniform spatiotemporal fractionation schemes within the standard BED model.
Unkelbach J; Papp D
Med Phys; 2015 May; 42(5):2234-41. PubMed ID: 25979017
[TBL] [Abstract][Full Text] [Related]
12. Impact of potentially variable RBE in liver proton therapy.
Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
[TBL] [Abstract][Full Text] [Related]
13. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
[TBL] [Abstract][Full Text] [Related]
14. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
[TBL] [Abstract][Full Text] [Related]
16. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
17. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
18. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
19. Treatment Planning Comparison for Carbon Ion Radiotherapy, Proton Therapy and Intensity-modulated Radiotherapy for Spinal Sarcoma.
Matsumoto K; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Yamaguchi T; Yoshitake T; Asai K; Kakiuchi G; Honda H
Anticancer Res; 2015 Jul; 35(7):4083-9. PubMed ID: 26124359
[TBL] [Abstract][Full Text] [Related]
20. A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.
Kim M; Stewart RD; Phillips MH
Med Phys; 2015 Nov; 42(11):6671-8. PubMed ID: 26520757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
